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www.cdatm.orgAbstractObjective: The continuous uninterrupted feedback system is the essential part of any well-organized system. We propose aLYNX
concept that is a possibility to use an artificial intelligence algorithm or a neural network model in decision-making system so as to
avoid possible mistakes and to remind the doctors to review tactics once more in selected cases.
Method: aLYNX system includes: registry with significant factors, decisions and results; machine learning process based on this
registry data; the use of the machine learning results as the adviser. We show a possibility to build a computer adviser with a
neural network model for making a choice between coronary aortic bypass surgery (CABG) and percutaneous coronary
intervention (PCI) in order to achieve a higher 5-year survival rate in patients with angina based on the experience of 5107
patients.
Results: The neural network was trained by 4679 patients who achieved 5-year survival. Among them, 2390 patients underwent
PCI and 2289 CABG. After training, the correlation coefficient (r) of the network was 0.74 for training, 0.67 for validation, 0.71 for
test and 0.73 for total. Simulation of the neural network function has been performed after training in the two groups of patients with
known 5-year outcome. The disagreement rate was significantly higher in the dead patient group than that in the survivor group
between neural network model and heart team [16.8% (787/4679) vs. 20.3% (87/428), P ¼ 0.065)].* Corresponding author. kv. 47, d. 54, Kommunisticheskaya str., Ufa, 450077, Russia.
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+ MODELConclusion: The study shows the possibility to build a computer adviser with a neural network model for making a choice between
CABG and PCI in order to achieve a higher 5-year survival rate in patients with angina.
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Contemporary guidelines of European Society of
Cardiology have approved the stable angina manage-
ment algorithm.1 The main alternatives are coronary
aortic bypass surgery (CABG) and percutaneous cor-
onary intervention (PCI). In case CABG is feasible and
there is anatomic possibility to perform PCI, there are
three groups of patients. The first group will benefit
from PCI because of good coronary anatomy and
perfect late results. These criteria are one- or two-
vessel disease without proximal left anterior descend-
ing artery stenosis, one-vessel disease with proximal
left anterior descending artery stenosis, two-vessel
disease with proximal left anterior descending artery
stenosis, left main disease with a SYNTAX score 22,
and three-vessel disease with a SYNTAX score 22.
The second group with left main disease with a
SYNTAX score >32 and three-vessel disease with a
SYNTAX score >22 will benefit from CABG because
of better late results despite the surgical trauma. The
third group seems to have balanced risks between the
late results of CABG and minimal invasion of PCI with
perfect immediate effect of PCI. This group is quite
large and accounts for more than half of all patients
after coronary angiography. For these people, decision
has to be made by a multidisciplinary heart team
including a doctor in charge, cardiologist, interven-
tional cardiologist and cardiovascular surgeon.
The first key point of this algorithm is SYNTAX
score. Although it is a useful and evidence-based tool,
some pitfalls do exist in its application. First, it is
based on the first-generation Taxus stent. Modern
materials can yield significantly better results, and
parameters have to be corrected in a real-time manner
in a changing world.2 Second, the SYNTAX score is
the mean result of a multicentre trial. Results can differ
from place to place in terms of skills, equipment and
resources. Third, genetics and treatment adherence
vary from place to place.3
Multidisciplinary approach is required in a multi-
vessel disease and it is recommended for patients who
are not covered by the institutional protocol discussed
by the heart team or when decision-making is complex.1Please cite this article in press as: Buzaev IVet al., Artificial intelligence: N
decision support to avoid medical mistakes, Chronic Diseases and TranslatHeart team is the second key point and another
weakness of this algorithm. Every member solves the
problems based on his knowledge and experiences.
Cardiovascular surgeon usually sees more often stent
restenosis than shunt failure because of the preliminary
selection at the coronary angiography stage by an
interventional cardiologist. Repeated CABG is rare and
difficult. An interventional cardiologist usually tries to
solve this problem without a cardiovascular surgeon.
An interventional cardiologist usually sees the symp-
tomatic patients and has a higher probability to see the
restenosis or shunt occlusion than in the real-world
situation. All these doctors are educated by statistics
of trials, but they may get misrepresented data which
are the reasons for mistakes. These errors can occur
mostly in rare and complex cases where a heart team
plays a significant role. Correct feedback is the
solution.
Patient-related factors, institutional factors and
referral patterns may influence the decision-making
process.1 There are various factors to be taken into
consideration by the physician, thus producing a lot of
uncertainties. Computation intelligence is one of the
approaches to dealing with such uncertainty in
decision-making.4,5 In this study, we proposed the
concept of artificial intelligence model as an assistant
in treatment-decision making and built a machine
adviser to make a choice between CABG and PCI for
patients with angina.
Methods
The first part of this concept is registry
We built up original software to gather the clinical
data. The first program was a database containing
medical electronic records of patients6 and software as
service on-line registry for follow-up.7 The system
collected feedback on health status from the patients
who underwent the PCI or CABG in our hospital.
General practitioners, doctors in charge or doctors of
our hospital who keep track of the patients are
responsible for sending the feedback data, which
include a number of factors that can be significant ineural network model as the multidisciplinary team member in clinical
ional Medicine (2016), http://dx.doi.org/10.1016/j.cdtm.2016.09.007
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+ MODELrevascularization choice and can be used immediately
to adjust decision-making process. The data were
expressed in measurable values to reflect the real sit-
uation and to make decision-making process more
unbiased and precise. Choice of revascularization
strategy is based not only on anatomy but also on
various factors. These factors can be patient-associated
and also dependent of the environment and process of
decision-making.
A total of 5107 patients who underwent CABG or
PCI during 2006e2010 were included in our registry.Table 1
Learning matrix factors.
Decision
1 Unstable angina
2 Myocardial infarction at admission
3 Stable angina
4 Age
5 Gender
6 Diabetes
7 Left ventricle aneurism
8 Akinesis
9 Diskinesis
10 Hypokinesis
11 Thrombus in left ventricle
12 Serum ALT more than 50 ЕD/L
13 Serum direct bilirubin 3.4 mmol/L
14 Serum urea more than 6.4 mmol/L
15 Serum creatinine 102 mmol/L
16 GFR
17 Disability
18 Living place
19 Atrial fibrillation
20 Serum glucose max
21 Maximum carotid stenosis
22 Atrial flutter
23 Rest heart rate
24 Cardiomyopathy
25 Chronic obstructive pulmonary disease
26 Echo: right ventrical pressure
27 Echo: right atrial size
28 Echo: right ventrical size
29 Echo: left ventricle end systolic size
30 Echo: systolic volume
31 Echo: left ventricle ejection fraction
32 Aortal regurgitation
33 Mitral regurgitation
34 Tricuspid regurgitation
35 Chronical heart failure, NYHA
36 SYNTAX
37 Coronary angio: number of cardiocycles contrast evacua
38 Echo: left ventricle end diasystolic volume
39 Echo: left ventricle end systolic volume
40 Muscle bridging
PCI: percutaneous coronary angioplasty, CABG: coronary aortic bypass sur
NYHA: New York Heart Association.
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dence in current trials and scores and hypothetical
ones. The 5-year outcomes were investigated. Death
was defined as the primary endpoint, because in
multifactor decision-making these factors can not only
result in cardiac death. Also the cause of death, stroke,
myocardial infarction and revascularization were
included in registry.
The patient characteristics were shown in Table 2
and Table 3. After coronary angiography, patients un-
derwent CABG or PCI in accordance with the1 e PCI 2 e CABG
1 e yes, 0 e no
1 e yes, 0 e no
1 e yes, 0 e no
Years
1 e male, 2 e female
1 e yes, 0 e no
1 e yes, 0 e no
1 e yes, 0 e no
1 e yes, 0 e no
1 e yes, 0 e no
1 e yes, 0 e no
1 e yes, 0 e no
1 e yes, 0 e no
1 e yes, 0 e no
1 e yes, 0 e no
ml/min
0, 1, 2, 3
0 e capital, 1 e small town, 2 e village
1 e yes, 0 e no
mmol/L
0 e no, 1 e < 50%, 2 e 50e75%, 3 e > 75%
1 e yes, 0 e no
1/min
1 e yes, 0 e no
1 e yes, 0 e no
mm Hg
cm
cm
cm
ml
%
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ml
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gery, ALT: alanine aminotransferase, GFR: glomerular filtration rate,
eural network model as the multidisciplinary team member in clinical
ional Medicine (2016), http://dx.doi.org/10.1016/j.cdtm.2016.09.007
Table 2
Characteristics of 5107 patients who underwent CABG or PCI during 2006e2010.
PCI CABG t P-value
Mean SD Mean SD
Age, years 57.70 9.13 58.45 8.01 3.1396 0.0017
Aortic regurgitation, 0.75 2.01 0.68 0.27 1.6161 0.1062
Disability level 1.32 1.36 1.64 1.30 8.6949 0.0000
Echo right atrium size, cm 3.96 0.37 3.99 0.40 2.4391 0.0148
Echo: ejection fraction, % 56.48 6.98 56.34 7.43 0.706 0.4803
Echo: left ventricle end diastolic size, cm 5.21 0.41 5.24 0.43 3.1233 0.0018
Echo: left ventricle end systolic size, cm 3.59 0.45 3.62 0.48 2.3868 0.0170
Echo: right atrium size, cm 4.64 0.38 4.65 0.43 1.4226 0.1549
Echo: right ventricle size, cm 2.34 0.23 2.34 0.24 0.2034 0.8388
Echo: systolic volume, ml 74.09 8.81 74.42 9.73 1.2965 0.1949
GFR, ml $ min1 $ 1.732 83.50 42.94 83.55 30.92 0.0494 0.9606
Rest heart rate, min1 61.98 5.71 61.82 6.12 0.9437 0.3454
Mean right ventricle pressure, mm Hg 28.51 3.25 28.49 3.79 0.243 0.8080
Serum glucose, mmol/L 6.06 2.07 5.95 1.59 2.2045 0.0275
Serum urea, mmol/L 7.37 4.70 8.14 5.60 5.3687 0.0000
SYNTAX score 17.76 9.14 32.62 10.05 55.3177 0.0000
Tricuspid regurgitation 1.13 0.24 1.10 0.33 3.3898 0.0007
PCI: percutaneous coronary angioplasty, CABG: coronary aortic bypass surgery, GFR: glomerular filtration rate.
Table 3
Characteristics of 5107 patients who underwent CABG or PCI during 2006e2010 (Chi-square).
Factor PCI (%) CABG (%) P-values (Pearson Chi-square)
Unstable angina 8.65 4.47 0.0000
Myocardial infarction at admission 33.65 4.39 0.0000
Stable angina 57.7 91.14 0.0000
Male 80.91 86.15 0.0000
Female 19.09 13.85 0.0000
Diabetes mellitus type 2 32.66 32.22 0.7366
Left ventricle aneurism 12.08 15.47 0.0004
Left ventricle diskinesis 4.69 5.07 0.5201
Left ventricle akinesis 19.09 22.43 0.0033
Left ventricle hypokinesis 79.69 81.8 0.0563
Thrombus in left ventricle 4.61 7.37 0.0000
Serum ALT more than 50 ED 41.24 40.93 0.8279
Serum direct bilirubin more than 3.4 mmol/L 7.65 7.91 0.7373
Serum urea more than 6.4 mmol/L 51.42 65.61 0.0000
Serum creatinine more than 102 mmol/L 18.13 18.41 0.8012
Disability group 3 31.97 37.01 0.0000
Village 28.35 34.07 0.0000
Atrial fibrillation 8.96 8.58 0.6337
Atrial flutter 1.52 1.77 0.4868
Cardiomyopathy 1.56 3.95 0.0000
Chronic obstructive pulmonary disease 3.43 4.31 0.1029
Muscle bridging 4.5 1.61 0.0000
PCI: percutaneous coronary angioplasty, CABG: coronary aortic bypass surgery, ALT: alanine aminotransferase.
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+ MODELdecisions of multidisciplinary heart team. Among these
5107 patients, 428 had reached the primary endpoint.
The 5-year survival was taken as the sign of right de-
cision. There were significant differences between PCI
and CABG group in age, renal function, urea, serumPlease cite this article in press as: Buzaev IVet al., Artificial intelligence: N
decision support to avoid medical mistakes, Chronic Diseases and Translatcreatinine, glucose levels, end systolic and end dia-
stolic volume of left ventricle, mitral, aortic and
tricuspid regurgitation and SYNTAX score. Patients
with low compensation of diabetes mellitus tend to
underwent PCI.eural network model as the multidisciplinary team member in clinical
ional Medicine (2016), http://dx.doi.org/10.1016/j.cdtm.2016.09.007
Fig. 1. Neural network architecture and education.
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To demonstrate the process we used a neural
network model. It was made by Neural Networks
pattern Recognition component of MATLAB R2014b
for MacOS i64.
The third part of approach is the use of the result as an
adviser
Data was analysed with Statsoft Statistica 6.0 soft-
ware (SPSS Inc. Chicago, IL, USA) using Pearson's
Chi-square test for 2  2 tables.
Results
The neural network was trained by 4679 patients
who achieved 5-year survival. Among them, 2390 pa-
tients underwent PCI and 2289 CABG. Fig. 1 shows
the Matlab window at the training stage. At the right
part of picture there are 2 matrices, one with the factors
and other with decisions.
Optimal architecture of the neural network has been
constructed using a cut-and-try method. The two-layer
feed-forward network was used for pattern recognition.
Input layer contained 12 neurons, and the second 1
neuron. 70% of patients had been randomly selectedPlease cite this article in press as: Buzaev IVet al., Artificial intelligence: N
decision support to avoid medical mistakes, Chronic Diseases and Translatfor training, 15% for validation and 15% for testing
(Fig. 1).
After training, the correlation coefficient (r) of the
network was 0.74 for training, 0.67 for validation, 0.71
for test and 0.73 for total (Fig. 2). Simulation of the
neural network function has been performed after
training in the two groups of patients with known 5-
year outcome. The first group survived and second
reached primary endpoint (II40_factors_dead ¼ II40
(factors_dead)). II40 is the neural network decision
function and II40_factors_dead is a vector with neural
network decision results. The network simulation
resulted in vector that was converted to table, where
the first column was patient identification, the second
5-year survival outcome, the third heart team decision,
the fourth neural network model decision (PCI or
CABG), the fifth the disagreement between human and
neural network model (“1” if yes, “0” if no).
The disagreement rate was significantly higher in
the dead patient group than that in the survivor group
between neural network model and heart team [16.8%
(787/4679) vs. 20.3% (87/428), P ¼ 0.065].
Discussion
The decision-making between CABG and PCI are
very complex and the accuracy of this machine advisereural network model as the multidisciplinary team member in clinical
ional Medicine (2016), http://dx.doi.org/10.1016/j.cdtm.2016.09.007
Fig. 2. Neural network training result.
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data collected by any registry that can be used for
training the neural network is not ensured. Second,
decision-making process in Heart Team lies not only on
the suitability for PCI vs. CABG, but also the prefer-
ences of surgeons or interventionists. It depends on the
institutional factors and reference patterns such as pro-
cedure waiting lists, equipment and stent availability.
For establishing an absolute and ideal adviser in the
future, the following functions are needed to be
developed. (1) Evidence-based guideline algorithm for
unambiguous criteria that is defined as absolute inPlease cite this article in press as: Buzaev IVet al., Artificial intelligence: N
decision support to avoid medical mistakes, Chronic Diseases and Translatguidelines. It must include absolute or near absolute
contraindications that exclude one alternative, absolute
or near absolute indications that prefer one option. For
example, this function will sort out CABG infeasible
patients or type III indications. This function must
select cases where at least one option is unacceptable
by the evidence or guidelines. (2) Particular context
function that suggests a complex multifactor decision-
making process when both options seems to be
acceptable. To solve this problem, fuzzy methodology
is useful. The place of aLYNX algorithm is here. (3)
Function that integrate the opinions of a group ofeural network model as the multidisciplinary team member in clinical
ional Medicine (2016), http://dx.doi.org/10.1016/j.cdtm.2016.09.007
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technique. Example of these techniques8 are Supra
Decision Maker (SDM),9 MAUT methods of group
decision,10 the WINGDSS software method,11
extended Analytic Hierarchy Process,12 PROM-
ETHEE procedure for group decision support,13
ELECTRE methodology.14
In addition, a fully functional artificial intelligence
adviser must explain why this decision is optimal.
The study shows the possibility to build a computer
adviser with a neural network model for making a
choice between CABG and PCI in order to achieve a
higher 5-year survival rate in patients with angina
based on the experience of 5107 patients.
Feedback system is the essential part of any well-
organized system. The continuous uninterrupted feed-
back results can be used as learning matrix. Neural
network relearning from updated matrix helps to make
decisions using new experience of exceptional cases,
thus improving decision-making.
aLYNX concept shows possibility to use an artificial
intelligence algorithm or a neural network model in
decision-making system so as to avoid possible mis-
takes and to remind the doctors to review tactics once
more in selected cases. Such system should include
registry with significant factors, decisions and results;
machine learning process based on the registry data;
using the machine learning results as the adviser.
We do hope that soulless machine will never make
decisions by itself in consideration of the ethical issues
and the real needs of patients, but correct learning
dataset including significant factors, tactics and late
results makes it possible to build a model to avoid
potential mistakes.
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